Australia's largest stock trading and investment forum Australia's #1 stock forum

CPH

0.00%

0.9¢ creso pharma limited

Ann: Creso signs distribution agreement in Switzerland - CannaQIX, page-95

First 95 Last

Share
Profile

Follow
Pilbars

1,167 Posts.

448

06/12/17

12:40

Post #: 29416616
Share

Originally posted by FraserJC ↑

The ambition is not the problem. The cost implications are.

In general, young companies flourish when they are really good at a small number of things. Then, as their reputation grows, they can branch into new products or markets. This approach minimises early cash-burn and significantly increases the chances of long-term success.

The reason is quite simple. A company's cost function depends on several variables, most importantly the:

1. number of products (SKUs) they produce or sell; and
2. number of geographic markets they serve.

It therefore follows that, the fewer products and the fewer geographic markets that a company enters, the lower its initial costs. Basically, concentrating on only one market or product line etc results in significant economies of scale, whereas a diversified start-up never reaches sufficient scale in any product or market to achieve said economies.

This is partly why 50% of all new firms die within 5 years (at least in NZ).

So, while I applaud CPH's ambition and vision, the financial realities paint a far less appealing picture to me.

DYOR etc.

Expand

In case any newbies are wondering , here's where we stand :

In one corner we have FrazerJC - Operating out of his mum's suburban bedsit in Regional New Zealand on his IPhone. Managed to break even on the NZ stock exchange the last couple of years.

In the other corner we have : http://cresopharma.com/profile/board-of-directors/

Who do you think has a better grasp of the Pharmaceutical industry and the direction the company should be headed ?

Here's a hint if you're still unsure - One of the two started an international company from scratch that multibagged and the other did SFA.

Last edited by Pilbars: 06/12/17

CPH Price at posting: 94.0¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

AI stocks: What to expect in 2024-25

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions